Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
MIT Technology Review
“Face2Gene, a facial recognition software tool that can aid in rare disease diagnosis. Face2Gene compares pictures of a patient’s face with those of disease composites and returns a series of potential diagnoses, from most plausible to least. The technology can differentiate specific individuals by being “trained” on multiple images of that person. Face2Gene’s technology, in contrast, identifies a pattern that is common to a group of people that have the same syndrome; establishing that common denominator allows the software to create a composite image associated with a condition.”
The article explains how Face2Gene, an innovative decision support tool developed by FDNA, utilizes facial recognition technology to assist in diagnosing rare genetic diseases through simple snapshots. The app analyzes facial features from photos to identify markers specific to various genetic disorders. Aimed at healthcare professionals, Face2Gene enhances precision in diagnosing conditions that might otherwise go unnoticed, thereby facilitating early intervention and tailored treatment plans. This groundbreaking technology combines artificial intelligence with genetic science to offer a non-invasive, accessible, and efficient solution for diagnosing rare genetic diseases, thereby significantly enhancing patient care and outcomes.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…